Date
- 2026 (24)
- 2025 (70)
- 2024 (100)
- 2023 (82)
- 2022 (63)
- 2021 (121)
- 2020 (150)
- 2019 (52)
- 2018 (53)
- 2017 (52)
- 2016 (4)
- 2015 (37)
- 2014 (22)
- 2013 (23)
- 2012 (12)
- 2011 (51)
- 2010 (45)
- 2009 (32)
- 2008 (27)
- 2007 (17)
- 2006 (21)
- 2005 (51)
- 2004 (12)
- 2003 (10)
- 2002 (9)
- 2001 (5)
- 2000 (5)
- 1999 (5)
- 1998 (9)
- 1997 (3)
- 1991 (3)
Sponsor content
1170 result(s) found, displaying 141 to 150
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DESVENLAFAXINE SANDOZ PHARMA desvenlafaxine 50 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BLOOMS THE CHEMIST SERTRALINE sertraline 100mg (as hydrochloride) film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BLOOMS THE CHEMIST SERTRALINE sertraline 50mg (as hydrochloride) film coated tablet blister pack.
-
Australian Public Assessment Report (AusPAR)Jubbonti (a biosimilar to Prolia), and Wyost (a biosimilar to XGEVA), were approved to improve bone density and to reduce bone fracture risk as a consequence of disease or medications that weaken bones.
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PEMETREXED SANDOZ pemetrexed (as disodium) 500 mg/20 mL concentrated solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PEMETREXED SANDOZ pemetrexed (as disodium) 100 mg/4 mL concentrated solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PEMETREXED SANDOZ pemetrexed (as disodium) 1000 mg/40 mL concentrated solution for infusion vial.
-